{"id":5508,"date":"2023-11-01T12:26:16","date_gmt":"2023-11-01T12:26:16","guid":{"rendered":"https:\/\/connectwithfund.com\/markets\/gsk-raises-guidance-on-strong-sales-of-arexvy-vaccine\/"},"modified":"2023-11-01T12:26:17","modified_gmt":"2023-11-01T12:26:17","slug":"gsk-raises-guidance-on-strong-sales-of-arexvy-vaccine","status":"publish","type":"post","link":"https:\/\/connectwithfund.com\/?p=5508","title":{"rendered":"GSK Raises Guidance on Strong Sales of Arexvy Vaccine"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"WP-BAR-0000786629\">\n<div data-layout=\"wrap\n              \" data-layout-mobile=\"\" class=\"\n        media-object\n        type-InsetMediaIllustration\n          wrap\n  article__inset\n        article__inset--type-InsetMediaIllustration\n          article__inset--wrap\n    article__inset--lead\n  \"><\/p>\n<p>        <!-- eventually when we know what this card will be we can change it and leave this one --><\/p>\n<figure class=\"\n        media-object-image\n        enlarge-image\n        img-wrap\n        article__inset__image\n      \" itemscope=\"\" itemtype=\"http:\/\/schema.org\/ImageObject\"><\/p>\n<\/figure><\/div>\n<p>British pharmaceuticals company<br \/>\n        GSK<br \/>\n       (ticker GSK) raised its outlook for the second time this year, pushing shares higher in early trading Wednesday.<\/p>\n<p>The company said that annual turnover will increase by 12% to 13%, compared with previous guidance of 8% to 10%. It expects adjusted operating profit to increase between 13% and 15%, up from prior guidance of 11% to 13%.\u00a0<\/p>\n<div class=\"paywall\">\n<p>GSK has been lifted by sales of its recently launched Arexvy vaccine that prevents a common respiratory disease. Arexvy\u2019s third-quarter sales were \u00a3709 million, easily beating analysts\u2019 expectations. Operating profit increased 15% in the third quarter from a year earlier, though the gains were offset by research investment, new product launches and lower Covid-19 medicine sales.\u00a0<\/p>\n<p>\u201cOur excellent execution supports an upgrade to our full-year 2023 guidance and we have clear momentum as we look ahead to deliver our 2026 outlooks,\u201d said Emma Walmsley, the chief executive officer.\u00a0<\/p>\n<p>GSK\u2019s London-traded shares were up 1.6%. Its American depositary receipts traded 0.3% higher in the premarket.<\/p>\n<p><em>This is a breaking news story. Below is a preview published before the results.<\/em><\/p>\n<p>The U.K. drugmaker<br \/>\n        GSK<br \/>\n       reports earnings Wednesday, in the midst of what\u2019s been a perilous season for pharmaceutical results.<\/p>\n<p>Shares of<br \/>\n        Bristol Myers Squibb<br \/>\n       (BMY),<br \/>\n        AbbVie<br \/>\n       (ABBV),<br \/>\n        Sanofi<br \/>\n       (SNY), and<br \/>\n        Amgen<br \/>\n       (AMGN) all fell following their financial results this earnings season. On Wednesday, it\u2019s GSK\u2019s (GSK) turn to face the market reaction after the company reports earnings.<\/p>\n<p>GSK\u2019s American depositary receipt has outperformed many of its pharma peers so far this year. Putting aside<br \/>\n        Eli Lilly<br \/>\n       (LLY) and<br \/>\n        Novo Nordisk<br \/>\n       (NVO)\u2014whose new anti-obesity medicines have driven dramatic spikes in their share prices\u2014GSK is among the best performers of the group. The GSK American depositary receipt is up roughly 1% so far this year, while the S&amp;P 500 Pharmaceuticals industry index has fallen 7%.<\/p>\n<p>Analysts expect GSK to report earnings of \u00a30.46 per share for the quarter on sales of \u00a37.7 billion ($9.4 billion) on Wednesday morning, according to FactSet.<\/p>\n<p>GSK will for the first time report sales of Arexvy, its new respiratory syncytial virus vaccine that launched this fall. The company expects the drug to grow into a megablockbuster. It competes with a similar shot from<br \/>\n        Pfizer<span>,<\/span><br \/>\n       which also launched this year.<\/p>\n<p>Pfizer said Tuesday it had sold $375 million worth of its RSV vaccine, Abrysvo, during the third quarter. Reuters reported Monday that two thirds of the RSV shots administered in the U.S. this season were GSK\u2019s Arexvy.<\/p>\n<p>In late October, GSK said it would seek expanded regulatory approval for Arexvy for adults aged 50 to 59, based on data from a new Phase 3 study. The shot is currently approved for adults aged 60 and above.<\/p>\n<p>GSK\u2019s American depositary receipt trades at 9.3 times earnings expected over the next 12 months, below its 5-year average of 12.7 times earnings.<\/p>\n<p>Write to Josh Nathan-Kazis at josh.nathan-kazis@barrons.com<\/p>\n<\/p><\/div>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/articles\/gsk-earnings-stock-price-7d01364b?mod=markets\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>British pharmaceuticals company GSK (ticker GSK) raised its outlook for the second time this year, pushing shares higher in early trading Wednesday. The company said that annual turnover will increase by 12% to 13%, compared with previous guidance of 8% to 10%. It expects adjusted operating profit to increase between 13% and 15%, up from prior guidance of 11% to 13%.\u00a0 GSK has been lifted by sales of its recently launched Arexvy vaccine that prevents a common respiratory disease. Arexvy\u2019s third-quarter sales were \u00a3709 million, easily beating analysts\u2019 expectations. Operating profit increased 15% in the third quarter from a year<\/p>\n","protected":false},"author":1,"featured_media":5509,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[39],"tags":[],"class_list":["post-5508","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-markets"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>GSK Raises Guidance on Strong Sales of Arexvy Vaccine | ConnectWithFund<\/title>\n<meta name=\"description\" content=\"British pharmaceuticals company GSK (ticker GSK) raised its outlook for the second time this year, pushing shares higher in early trading Wednesday. The\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/connectwithfund.com\/?p=5508\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK Raises Guidance on Strong Sales of Arexvy Vaccine | ConnectWithFund\" \/>\n<meta property=\"og:description\" content=\"British pharmaceuticals company GSK (ticker GSK) raised its outlook for the second time this year, pushing shares higher in early trading Wednesday. The\" \/>\n<meta property=\"og:url\" content=\"https:\/\/connectwithfund.com\/?p=5508\" \/>\n<meta property=\"og:site_name\" content=\"ConnectWithFund\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-01T12:26:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-01T12:26:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/connectwithfund.com\/wp-content\/uploads\/2023\/11\/1698841577_social.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/connectwithfund.com\/?p=5508\",\"url\":\"https:\/\/connectwithfund.com\/?p=5508\",\"name\":\"GSK Raises Guidance on Strong Sales of Arexvy Vaccine | ConnectWithFund\",\"isPartOf\":{\"@id\":\"https:\/\/connectwithfund.com\/#website\"},\"datePublished\":\"2023-11-01T12:26:16+00:00\",\"dateModified\":\"2023-11-01T12:26:17+00:00\",\"author\":{\"@id\":\"https:\/\/connectwithfund.com\/#\/schema\/person\/9344cb2de07361e178f5c834d2167e52\"},\"description\":\"British pharmaceuticals company GSK (ticker GSK) raised its outlook for the second time this year, pushing shares higher in early trading Wednesday. The\",\"breadcrumb\":{\"@id\":\"https:\/\/connectwithfund.com\/?p=5508#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/connectwithfund.com\/?p=5508\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/connectwithfund.com\/?p=5508#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/connectwithfund.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK Raises Guidance on Strong Sales of Arexvy Vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/connectwithfund.com\/#website\",\"url\":\"https:\/\/connectwithfund.com\/\",\"name\":\"FinMarkPros\",\"description\":\"Latest Finance News and Updates\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/connectwithfund.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/connectwithfund.com\/#\/schema\/person\/9344cb2de07361e178f5c834d2167e52\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/connectwithfund.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3740b286006c76c86a45c4879850da000667bb6f5bbe053edd4a416d2cc4fb80?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3740b286006c76c86a45c4879850da000667bb6f5bbe053edd4a416d2cc4fb80?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/connectwithfund.com\"],\"url\":\"https:\/\/connectwithfund.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GSK Raises Guidance on Strong Sales of Arexvy Vaccine | ConnectWithFund","description":"British pharmaceuticals company GSK (ticker GSK) raised its outlook for the second time this year, pushing shares higher in early trading Wednesday. The","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/connectwithfund.com\/?p=5508","og_locale":"en_US","og_type":"article","og_title":"GSK Raises Guidance on Strong Sales of Arexvy Vaccine | ConnectWithFund","og_description":"British pharmaceuticals company GSK (ticker GSK) raised its outlook for the second time this year, pushing shares higher in early trading Wednesday. The","og_url":"https:\/\/connectwithfund.com\/?p=5508","og_site_name":"ConnectWithFund","article_published_time":"2023-11-01T12:26:16+00:00","article_modified_time":"2023-11-01T12:26:17+00:00","og_image":[{"width":1280,"height":640,"url":"https:\/\/connectwithfund.com\/wp-content\/uploads\/2023\/11\/1698841577_social.jpeg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/connectwithfund.com\/?p=5508","url":"https:\/\/connectwithfund.com\/?p=5508","name":"GSK Raises Guidance on Strong Sales of Arexvy Vaccine | ConnectWithFund","isPartOf":{"@id":"https:\/\/connectwithfund.com\/#website"},"datePublished":"2023-11-01T12:26:16+00:00","dateModified":"2023-11-01T12:26:17+00:00","author":{"@id":"https:\/\/connectwithfund.com\/#\/schema\/person\/9344cb2de07361e178f5c834d2167e52"},"description":"British pharmaceuticals company GSK (ticker GSK) raised its outlook for the second time this year, pushing shares higher in early trading Wednesday. The","breadcrumb":{"@id":"https:\/\/connectwithfund.com\/?p=5508#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/connectwithfund.com\/?p=5508"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/connectwithfund.com\/?p=5508#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/connectwithfund.com\/"},{"@type":"ListItem","position":2,"name":"GSK Raises Guidance on Strong Sales of Arexvy Vaccine"}]},{"@type":"WebSite","@id":"https:\/\/connectwithfund.com\/#website","url":"https:\/\/connectwithfund.com\/","name":"FinMarkPros","description":"Latest Finance News and Updates","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/connectwithfund.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/connectwithfund.com\/#\/schema\/person\/9344cb2de07361e178f5c834d2167e52","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/connectwithfund.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3740b286006c76c86a45c4879850da000667bb6f5bbe053edd4a416d2cc4fb80?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3740b286006c76c86a45c4879850da000667bb6f5bbe053edd4a416d2cc4fb80?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/connectwithfund.com"],"url":"https:\/\/connectwithfund.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/posts\/5508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5508"}],"version-history":[{"count":1,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/posts\/5508\/revisions"}],"predecessor-version":[{"id":5510,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/posts\/5508\/revisions\/5510"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=\/wp\/v2\/media\/5509"}],"wp:attachment":[{"href":"https:\/\/connectwithfund.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/connectwithfund.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}